Login / Signup

Warfarin dose requirement in patients having severe thrombosis or thrombophilia.

Tuukka Antero HelinLotta Joutsi-KorhonenHeidi AsmundelaMikko NiemiArto OrpanaRiitta Lassila
Published in: British journal of clinical pharmacology (2019)
In severe thrombosis and/or thrombophilia, variation in thrombin generation and pharmacodynamics influences warfarin response. Pharmacogenetic dosing algorithms seem to underestimate dose requirement.
Keyphrases
  • pulmonary embolism
  • atrial fibrillation
  • venous thromboembolism
  • newly diagnosed
  • ejection fraction
  • machine learning
  • early onset
  • direct oral anticoagulants
  • prognostic factors
  • oral anticoagulants